Familial adenomatous polyposis

Search Trials
Effect of EPA-FFA on Polypectomy in Familial Adenomatous Polyposis
Status:
Recruiting
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Familial Adenomatous Polyposis
Intervention(s):
Eicosapentaenoic acid free fatty acid (EPA-FFA)Placebo
Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)
Status:
Terminated
Last Changed:
Mar 11, 2014
First Changed:
Mar 1, 2008
Disease(s):
Adenomatous Polyposis Coli
Intervention(s):
CelecoxibPlacebo
Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA
Status:
Completed
Last Changed:
Jan 1, 1970
First Changed:
Feb 8, 2007
Disease(s):
Familial Adenomatous Polyposis Coli
Intervention(s):
Eicosapentanoic Acid (EPA)EndoscopyBiopsies takenPlacebo
Sirolimus and Familial Adenomatous Polyposis (FAP)
Status:
Completed
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Adenomatous Polyposis Coli
Intervention(s):
Sirolimus
A Study of Guselkumab in Participants With Familial Adenomatous Polyposis
Status:
Recruiting
Last Changed:
Apr 1, 2019
First Changed:
Jan 1, 1970
Disease(s):
Adenomatous Polyposis Coli
Intervention(s):
GuselkumabPlacebo

Connect. Empower. Inspire.